Appearance of oral Gaucher disease treatment, ‘Cerdelga’
Sanofi Genzyme has started to enter competition in the Gaucher disease treatment market as launching Cerdelga(generic name: eliglustat), an oral Gaucher disease treatment, with the health insurance benefits.
Sanofi Genzyme held a press conference to celebrate the launch of Cerdelga, an oral trea...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
